CClinicalTrials.gg
Status unknownNCT05381545Updated May 19, 2022

Laser Puncture and Program of Lifestyle Modification in Lupus Females

An interventional study of laser puncture, energy expenditure programming, and low-calories recommended diet programming and energy expenditure programming and low-calories recommended diet programming in Systemic Lupus Erythematosus, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-05-19.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Serum lipid profile was significantly dysregulated in female systemic lupus erythematosus (SLE) patients

Read the detailed description

the research will recruit 64 female systemic lupus erythematosus (SLE) obese patients to divide them to two study groups equally. the study groups will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week, combined with low calorie diet for).One group only will receive an additional laser puncture (with 3-time per-week design). The following points will be directly contacted by laser, for two minutes: GB34\&28, ST25\&36\&40, SP6, and CV4\&9\&12.

02

Conditions studied

  • Systemic Lupus Erythematosus
03

In context

Lupus Erythematosus, Systemic

1,202 studies on the registry are indexed under Lupus Erythematosus, Systemic; 399 are open to participants now.

This study's planned enrollment of 64 is above the median of 50 across 867 interventional studies indexed under Lupus Erythematosus, Systemic.

Browse Lupus Erythematosus, Systemic studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • obese female participants
  • Lupus females

Exclusion criteria

Exclusion Criteria:

  • pregnant lupus female
  • lactating lupus females
  • neurologic or articular disorders
  • another autoimmune conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    group A

    This 32-patient research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week, combined with low calorie diet for).This research group will receive an additional laser puncture (with 3-time per-week design). The following points will be directly contacted by laser, for two minutes: GB34\&28, ST25\&36\&40, SP6, and CV4\&9\&12.

    Behavioral: laser puncture, energy expenditure programming, and low-calories recommended diet programming

  • Active comparator
    Group B

    This 32-patient research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week, combined with low calorie diet ).

    Behavioral: energy expenditure programming and low-calories recommended diet programming

Interventions

  • Behaviorallaser puncture, energy expenditure programming, and low-calories recommended diet programming

    This research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week) combined with low calorie diet .This research group will receive an additional laser puncture (with 3-time per-week design). The following points will be directly contacted by laser, for two minutes: GB34\&28, ST25\&36\&40, SP6, and CV4\&9\&12.

  • Behavioralenergy expenditure programming and low-calories recommended diet programming

    This research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week) combined with low calorie diet.

06

What researchers measure

Primary outcomes

  1. triglycerides

    a lipid component will be measured in blood of females

    Time frame: 12 weeks

Secondary outcomes

  1. high density lipoprotein

    a lipid component will be measured in blood of females

    Time frame: 12 weeks

  2. cholesterol

    a lipid component will be measured in blood of females

    Time frame: 12 weeks

  3. low density lipoprotein

    a lipid component will be measured in blood of females

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy Cairo University
    Giza, Dokki, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05381545
Lead sponsor
Cairo University
Responsible party
Ali Mohamed Ali ismail (lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo University) — Principal investigator
First posted
May 19, 2022
Start date
Feb 28, 2022
Primary completion
Jul 1, 2022 (estimated)
Completion
Jul 1, 2022 (estimated)
Last update
May 19, 2022

Study contacts

Ali Ismail, lecturer
Contact
allooka2012@gmail.com
02 01005154209
Ali Ismail, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion